A new strategy to attack aggressive brain cancer shrank tumors in two early tests
A new strategy to fight an extremely aggressive type of brain tumor showed promise in a pair of experiments with a handful of patients.
Mar 14, 2024
0
57
Amino Acids, Peptides, and Proteins: News and Research on Receptor Protein-Tyrosine Kinases
MeSH tree: D12.776.476.568.400
Advancing the generation of in-vivo chimeric lungs in mice using rat-derived stem cells
Chronic obstructive pulmonary disease (COPD) is the third-leading cause of death worldwide. It is marked by lung damage that is lasting and incurable, leaving lung transplantation as the only viable treatment option. Unfortunately, ...
Jan 5, 2024
0
40
Organoids study discovers promising treatment for deadly uterine cancer
QUT scientists have discovered a promising new therapy for a deadly type of endometrial cancer that has a poor prognosis if the cancer spreads or returns after initial treatment, a plight that affects 15%–20% of endometrial ...
Dec 13, 2023
0
42
New cause of diabetes discovered, offering potential target for new classes of drugs to treat the disease
Researchers at Case Western Reserve University and University Hospitals have identified an enzyme that blocks insulin produced in the body—a discovery that could provide a new target to treat diabetes.
Dec 8, 2023
0
96
Study directly links high insulin levels to pancreatic cancer
A new study from researchers at the University of British Columbia's Faculty of Medicine reveals a direct link between high insulin levels, common among patients with obesity and type 2 diabetes, and pancreatic cancer.
Oct 31, 2023
0
146
Research links single gene to female infertility
Loss of a single gene could be enough to cause female infertility, with research identifying that women won't make eggs without the protein it produces.
Oct 25, 2023
0
32
Trial finds adding immune modulator to targeted therapy does not improve survival in difficult-to-treat thyroid cancer
Results of a multicenter phase II clinical trial led by the University of Chicago Medicine Comprehensive Cancer Center show that adding an immunomodulatory agent to treatment with the targeted tyrosine kinase inhibitor (TKI) ...
Sep 1, 2023
0
52
Patients with refractory metastatic colorectal cancer experience survival benefits with fruquintinib
Researchers from The University of Texas MD Anderson Cancer Center reported study results showing that the targeted therapy fruquintinib significantly improved overall survival (OS) and progression-free survival (PFS) in ...
Jun 16, 2023
0
66
How hepatitis E viruses enter cells
Although hepatitis E is a common disease, little is known about the life cycle of the virus. Initial findings on how it manages to infect cells are reported by a team from Molecular and Medical Virology at Ruhr University ...
Feb 9, 2023
0
38
Genetic deficiency and pharmacological modulation of RORα regulate laser-induced choroidal neovascularization
A new research paper titled "Genetic deficiency and pharmacological modulation of RORα regulate laser-induced choroidal neovascularization" has been published in Aging.
Jan 18, 2023
0
56
